In the News | Friends of Cancer Research

You are here

In the News

September 10, 2020
In keeping with her Presidential theme of “Equity: Every Patient, Every Day, Everywhere,” in July, ASCO President Lori J. Pierce, MD, FASTRO, FASCO, announced the Society was joining forces with the... Read more
August 25, 2020
The development of complex biomarkers such as tumor mutational burden (TMB) has enabled clinicians to identify patients more likely to respond to treatment of a variety of cancers, leading to more... Read more
August 18, 2020
Randomized controlled trials are the accepted standard for evaluating investigational therapies, but such trials are sometimes not an option for reasons of ethics or feasibility. Here, we discuss... Read more
August 18, 2020
Patients living with HIV (PLWH) must take daily medications to suppress the virus, despite significant advancements in antiretroviral therapy (ART).   A major limitation of ART is that it is only... Read more
August 17, 2020
FDA is using real-world data to better understand and answer questions about potential COVID-19 therapies, and remdesivir is the next therapy in the spotlight. Through its real-world evidence public-... Read more
August 5, 2020
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest... Read more
August 3, 2020
Abstract: Health professionals agree that increasing diversity in clinical trial participants is an important way to improve cancer care and address disparities in outcomes. However, trial... Read more
July 31, 2020
The FDA’s Oncology Center of Excellence and Syapse presented data at the American Association of Clinical Research COVID-19 and Cancer meeting on an analysis of more than 212,000 health records of... Read more
July 31, 2020
In prepared witness testimony, leaders of the nation’s three top agencies battling the coronavirus outbreak describe their months-long efforts to develop testing, treatments and possible vaccines to... Read more
July 27, 2020
David R. Gandara, MD, discusses the current state of tumor mutational burden in lung cancer, ongoing research further examining the utility of this biomarker, and challenges to address with future... Read more

Pages